Pharmaceutical companies invest in the discovery, development, manufacture and distribution of new drugs and therapies for the treatment of diseases.
The PRISM Emerging Pharma Index tracks small and micro-cap stocks that are contributing to driving innovation to improve healthcare for all.
| PRISM Emerging Pharmaceuticals IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| -0.5% | $156.40 | 56.4% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
| TFF Pharmaceuticals, Inc. | TFFP | $0.07 | -60.049% | 11,020 | 1,653 | $0 | $6.91 | -99.1% |
| IO Biotech, Inc. | IOBT | $0.91 | 2.293% | 291 | 350 | $60 | $1.91 | -52.4% |
| OKYO Pharma Limited | OKYO | $1.07 | -0.467% | 7 | 56 | $36 | $1.94 | -45.1% |
| Kala Pharmaceuticals, Inc. | KALA | $6.24 | 4% | 38 | 26 | $29 | $6.95 | -10.2% |
| Lipella Pharmaceuticals Inc. | LIPO | $3.16 | 1.672% | 45 | 191 | $4 | $0.94 | 236.1% |
| Leap Therapeutics, Inc. | LPTX | $2.91 | 0.692% | 22 | 362 | $112 | $4.67 | -37.7% |
| Quoin Pharmaceuticals, Ltd. | QNRX | $0.49 | -7.069% | 278 | 3,276 | $2 | $4.84 | -90.0% |
| Oramed Pharmaceuticals Inc. | ORMP | $2.38 | 0% | 62 | 137 | $96 | $2.45 | -2.9% |
| ESSA Pharma Inc. | EPIX | $1.61 | -1.227% | 39 | 901 | $71 | $6.45 | -75.0% |
| Fennec Pharmaceuticals Inc. | FENC | $6.19 | -0.322% | 44 | 120 | $170 | $11.12 | -44.3% |
| Cumberland Pharmaceuticals Inc. | CPIX | $2.51 | 11.556% | 166 | 1,805 | $35 | $1.85 | 36.0% |
| Lumos Pharma, Inc. | LUMO | $4.34 | 0% | 391 | 98 | $38 | $3.22 | 34.8% |
| Merrimack Pharmaceuticals, Inc. | MACK | $15.15 | 0.099% | 923 | 183 | $224 | $13.31 | 13.8% |
| CorMedix Inc. | CRMD | $8.33 | -1.069% | 230 | 1,187 | $505 | $3.77 | 121.0% |
| Atea Pharmaceuticals, Inc. | AVIR | $3.25 | 0.309% | 174 | 269 | $275 | $3.21 | 1.2% |
| Tonix Pharmaceuticals Holding Corp. | TNXP | $0.39 | -4.416% | 73,478 | 94,967 | $72 | $0.42 | -7.8% |
| Armata Pharmaceuticals, Inc. | ARMP | $2.04 | 5.16% | 5 | 9 | $74 | $3.10 | -34.2% |
| Galmed Pharmaceuticals Ltd. | GLMD | $3.04 | 3.051% | 11 | 116 | $5 | $0.44 | 591.4% |
| Syros Pharmaceuticals, Inc. | SYRS | $0.20 | -0.49% | 908 | 8,581 | $5 | $7.84 | -97.4% |
| Hepion Pharmaceuticals, Inc. | HEPA | $0.50 | 0.382% | 19 | 44 | $3 | $3.15 | -84.1% |
| Athira Pharma, Inc. | ATHA | $0.54 | 5.632% | 123 | 4,766 | $21 | $2.89 | -81.2% |
| Actinium Pharmaceuticals, Inc. | ATNM | $1.23 | -0.807% | 140 | 303 | $38 | $5.32 | -76.9% |
| Rigel Pharmaceuticals, Inc. | RIGL | $16.44 | -4.14% | 491 | 227 | $290 | $1.46 | 1,026.0% |
| Biodexa Pharmaceuticals Plc | BDRX | $4.29 | 12.285% | 6 | 285 | $997 | $2.69 | 59.5% |
| Moleculin Biotech, Inc. | MBRX | $1.82 | 5.202% | 23 | 49 | $6 | $13.86 | -86.9% |
| Candel Therapeutics, Inc. | CADL | $8.80 | 1.97% | 1,094 | 3,285 | $391 | $1.45 | 506.9% |
| PharmaTher Holdings Ltd. | PHRRF | $0.16 | -3.125% | 6 | 360 | $14 | $0.25 | -38.0% |
| Corvus Pharmaceuticals, Inc. | CRVS | $4.90 | 7.692% | 657 | 1,093 | $315 | $1.76 | 178.4% |
| Trevi Therapeutics, Inc. | TRVI | $4.00 | -1.478% | 441 | 1,699 | $357 | $1.30 | 207.7% |
| Galectin Therapeutics Inc. | GALT | $0.84 | -5.561% | 1,693 | 482 | $52 | $1.74 | -51.7% |
| MannKind Corporation | MNKD | $6.74 | -3.989% | 1,412 | 2,618 | $1,859 | $3.92 | 71.9% |
| Applied Therapeutics, Inc. | APLT | $0.85 | -1.742% | 2,950 | 5,162 | $99 | $3.64 | -76.6% |
| Rockwell Medical, Inc. | RMTI | $2.15 | 1.896% | 136 | 743 | $69 | $1.86 | 15.6% |
| Alpha Teknova, Inc. | TKNO | $8.60 | 11.979% | 633 | 234 | $458 | $3.80 | 126.3% |
| Opus Genetics, Inc. | IRD | $1.04 | 0.971% | 170 | 190 | $33 | $3.07 | -66.1% |
| Adial Pharmaceuticals, Inc. | ADIL | $1.05 | 1.942% | 62 | 174 | $7 | $1.75 | -40.0% |
